Use of etidronate (ehdp) in paget's dise
โ
C. Conrad Johnston Jr; M. R. A. Khairi; P. J. Meunier
๐
Article
๐
1980
๐
John Wiley and Sons
๐
English
โ 382 KB
๐ 1 views
## Abstract Etidronate used in recommended doses (usually 5 mg/kg/day for 6 months) produces symptomatic improvement in approximately 60% of patients. The serum alkaline phosphatase and urinary hydroxyproline are reduced to about 50% of initial values. A sustained remission occurs in many patients